Overview

Drug-Drug Interaction (DDI) Study in Healthy Volunteers

Status:
Active, not recruiting
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
A Phase 1, Open Label, Fixed Sequence Study to Evaluate the Effect of BLD-0409 on the Single Dose Pharmacokinetics of a Cocktail of Probe Substrates for CYP450 Enzymes in Healthy Volunteers
Phase:
Phase 1
Details
Lead Sponsor:
Blade Therapeutics